SCHEMBL2899675

SCHEMBL2899675

Brc1ccc(-n2cnc(I)c2)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.37
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
AKR1C3 P42330 1/20 0.33
ALDH1A1 P00352 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
NLRP3 Q96P20 1/20 0.33
KDM4E B2RXH2 2/20 0.32
CPB2 Q96IY4 1/20 0.31
MAPT P10636 1/20 0.31
PLAU P00749 1/20 0.30
ADRA2A P08913 1/20 0.30
ADRA2B P18089 1/20 0.30
ADRA2C P18825 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27381147 0.81 GRIN2D (0.38) GBA1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL31087014 0.79 CYP2E1 (0.44) GBA1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL17443527 0.75 GRIN2D (0.41) GBA1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL3100906 0.75 PDE3B (0.39) GBA1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2899625 0.75 KCNJ1 (0.36) GBA1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL3076464 0.75 GBA1 (0.38) GBA1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2899406 0.75 GRIN2D (0.34) GBA1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2890582 0.75 GRIN2D (0.37) GBA1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2893816 0.73 NPC1 (0.65) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2894504 0.73 KDM4E (0.54) AKR1C3ALDH1A1KDM4ECPB2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286211-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS RANBAXY LABORATORIES LIMITED (IN) 2010-11-11 US disclosed
EP-1799677-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS Ranbaxy Laboratories Limited (IN) 2007-06-27 EP disclosed
WO-2006038100-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS RANBAXY LABORATORIES LIMITED (IN) 2006-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286211-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS OXA1L, PDK4, MLYCD GBA1 2894/4885GRIN2D 3147/4885GRIN3B 3844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.